Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays

Journal of Immunological Methods

Volumn 306, Issue 1-2, 2005, Pages 161-168

  Langhans, Bettina ^a   Ahrendt, Manuela ^a   Nattermann, Jacob ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

51Cr release assay; Cell mediated cytotoxicity; Flow cytometric cytotoxicity assays; Natural killer (NK) cells

Indexed keywords

CHROMIUM 51;

ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL STRAIN K 562; CELL SURVIVAL; CYTOTOXICITY TEST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKEMIA CELL LINE; LYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; RADIOACTIVITY; SENSITIVITY ANALYSIS; TARGET CELL;

CASPASE 3; CASPASE 6; CASPASES; CESIUM RADIOISOTOPES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; LYMPHOCYTES;

EID: 28444491128     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.08.010     Document Type: Article

References (22)

1. S.I. Abrams, and Z. Brahmi The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism Cell. Immunol. 101 1986 558 570
2. D.O. Adams, T. Hall, Z. Steplewski, and H. Koprowski Tumors undergoing rejection induced by monoclonal antibodies of the IgG2A Isotyp contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis Proc. Natl. Acad. Sci. U. S. A. 81 1984 3506 3510
3. K.T. Brunner, J. Manel, J.C. Cerottini, and B. Chapins Quantitative assay of the lytic action of immune lymphoid cells on 51cr labelled allogenic targets cells J. Immunol. 14 1968 181 186
4. I. Csipo, A.H. Montel, J.A. Hobbs, P.A. Morse, and Z. Brahmi Effect of Fas+ and Fas-target cells on the ability of NK cells to repeatedly fragment DNA and trigger lysis via the Fas lytic pathway Apoptosis 3 1998 105 114
5. U. Düesberg, A.M. Schneiders, D. Flieger, G. Inchauspé, T. Sauerbruch, and U. Spengler Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C J. Hepatol. 35 2001 650 657
6. D. Flieger, R. Gruber, G. Schlimok, C. Reiter, K. Pantel, and G. Riethmüller A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells J. Immunol. Methods 180 1995 1 13
7. Jakubek, E. Thorsby, and H. Hirschberg Cell mediated lympholysis; a modified technique using 111indium-oxine-labelled targets J. Immunol. Methods 60 1983 379 390
8. H.R. Kim, H.J. Park, J.H. Park, S.J. Kim, K. Kim, and J. Kim Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B Can. Immunol. Immunother. 53 2004 461 470
9. L. Liu, A. Chahroudi, G. Silvestri, M.E. Wernett, W.J. Kaiser, and J.T. Safrit Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates Nat. Med. 8 2002 185 189
10. S.J. Lord, R.V. Rajotte, G.S. Korbutt, and R.C. Bleackley Granzyme B: a natural born killer Immunol. Rev. 193 2003 31 38
11. C.B. Lozzio, and B.B. Lozzio Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome Blood 45 1975 321 334
12. P. Matzinger The JAM test: a simple assay for DNA fragmentation and cell death J. Immunol. Methods 145 1991 185 192
13. S. Nagata Fas ligand-induced apoptosis Annu. Rev. Genet. 33 1999 29 55
14. C. Renvoizé, R. Roger, N. Moulian, J. Bertoglio, and J. Bréard Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK an lymphokine-activates killer cell granule-mediates apoptosis J. Immunol. 159 1997 126 134
15. M.J. Robertson, K.J. Cochran, C. Cameron, J.M. Le, R. Tantravahi, and J. Ritz Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia Exp. Hematol. 24 1996 406 415
16. J.H. Russell, and T.J. Ley Lymphocyte-mediated cytotoxicity Annu. Rev. Immunol. 20 2002 323 370
17. U. Schneider, H.U. Schwenk, and G. Bornkamm Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma Int. J. Cancer 19 1977 621 626
18. V. Screpanti, R.P. Wallin, H.G. Ljunggren, and A. Grandien A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells J. Immunol. 167 4 2001 2068 2073
19. V. Screpanti, R.P. Wallin, A. Grandien, and H.G. Ljunggren Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells Mol. Immunol. 42 4 2005 495 499
20. Y. Shounan, X. Fang, and P.J. ÓConnell Apoptosis detection by annexin V binding: a novel method for the quantitation of cell-mediated cytotoxicity J. Immunol. Methods 217 1998 61 70
21. M.J. Smyth, E. Cretney, J.M. Kelly, J.A. Westwood, S.E. Street, H. Yagita, K. Takeda, S.L. van Dommelen, M.A. Degli-Esposti, and Y. Hayakawa Activation of NK cell cytotoxicity Mol. Immunol. 45 4 2005 501 510
22. J.A. Trapani, and M.J. Smyth Functional significance of the perforin/granzyme cell death pathway Nat. Rev. 2 10 2002 735 747